Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
NPJ Breast Cancer|April 27, 2026
Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trialJoyce O'Shaughnessy, Francois-Clement Bidard, Patrick Neven, et al.
Acta Oncologica (Stockholm, Sweden)|August 22, 2020
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panelGiacomo Bregni, Tiberio Sticca, Silvia Camera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2024
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)Nicholas Turner, Cristina Saura, Philippe Aftimos, et al.
The Lancet. Oncology|May 6, 2024
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 studyBob T Li, Funda Meric-Bernstam, Aditya Bardia, et al.
Breast (Edinburgh, Scotland)|July 4, 2021
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterationsFabio Conforti, Laura Pala, Eleonora Pagan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2019
Lucitanib for the Treatment of HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE StudyRina Hui, Alex Pearson, Javier Cortes, et al.
Cell Reports. Medicine|February 21, 2025
Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancerChristina Metoikidou, Vadim Karnaukhov, Bram Boeckx, et al.
Breast Cancer Research and Treatment|June 15, 2023
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cellsTaronish D Dubash, Aditya Bardia, Brian Chirn, et al.
JAMA Oncology|November 17, 2022
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic TrialAlison M Schram, Nicoletta Colombo, Edward Arrowsmith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Molecular and clinical analyses of gene fusions identify therapeutic targets in paired primary and metastatic breast cancer from the AURORA program (BIG 14-01)Chiara Biagioni, Danai Fimereli, Alexandre Irrthum, et al.
Pageof 9